β-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge

Journal of General Virology

Volumn 80, Issue 7, 1999, Pages 1569-1574

  Ahmed, Raija K S ^a   Nilsson, Charlotta ^a   Wang, Yufei ^b   Lehner, Thomas ^b   Biberfeld, Gunnel ^a   Thorstensson, Rigmor ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHEMOKINE; LIVE VACCINE; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ENVIRONMENTAL FACTOR; HEREDITY; MACACA; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VACCINATION; VIRUS INFECTION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MACACA; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0033029835     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-7-1569     Document Type: Article

References (47)

1. mac251 infected macaques previously immunized with NYVAC-SIV vaccines. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1, S78-S85.
2. Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M. & Berger, E. A. (1996). CC CKR-5 : a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958.
3. Alkhatib, G., Liao, F., Berger, E. A., Farber, J. M. & Peden, K. W. C. (1997). A new SIV co-receptor, STRL33. Nature 388, 238.
4. Andersson, S., Mäkitalo, B., Thorstensson, R., Franchini, G., Tartaglia, J., Limbach, K., Paoletti, E., Putkonen, P. & Biberfeld, G. (1996). Immunogenicity and protective efficacy of a human immunodeficiency virus type 2 recombinant canarypox (ALVAC) vaccine candidate in cynomolgus monkeys. Journal of Infectious Diseases 174, 977-985.
5. Baier, M., Werner, A., Bannert, N., Metzner, K. & Kurth, R. (1995). HIV suppression by interleukin-16. Nature 378, 563.
6. Blackbourn, D. J., Locher, C. P., Ramachandran, B., Barnett, S. W., Murthy, K. K., Carey, K. D., Brasky, K. M. & Levy, J. A. (1997). CD8+ cells from HIV-2 infected baboons control HIV replication. AIDS 11, 737-746.
7. Chen, Z., Zhou, P., Ho, D. D., Landau, N. R. & Marx, P. A. (1997). Genetically divergent strains of simian immunodeficiency viruses use CCR5 as a coreceptor for entry. Journal of Virology 71, 2705-2714.
8. Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G., Newman, W., Gerard, N., Gerard, C. & Sodroski, J. (1996). The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148.
9. Cocchi, F., DeVico, A. L., Garzino-Demo, A., Araya, S. K., Gallo, R. C. & Lusso, P. (1995). Identification of RANTES, MIP-1α and MIP-1β as the major HIV-suppressive factors produced by CD8+ cells. Science 270, 1811-1815.
10. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R. & Landau, N. R. (1996). Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666.
11. Deng, H., Unutmaz, D., KewalRamani, V. N. & Littman, D. R. (1997). Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388, 296-300.
12. Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G. & Doms, R. W. (1996). A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3 and CKR-2b as fusion cofactors. Cell 85, 1149-1158.
13. Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P. & Paxton, W. A. (1996). HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667-673.
14. Ennen, J., Findeklee, H., Dittmar, M. T., Norley, S., Ernst, M. & Kurth, R. (1994). CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine. Proceedings of the National Academy of Sciences, USA 91, 7207-7211.
15. Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. (1996). HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 272, 872-877.
16. Furci, L., Scarlatti, G., Burastero, S., Tambussi, G., Colognesi, C., Quillent, C., Longhi, R., Loverro, P., Borgonovo, B., Gaffi, D., Carrow, E., Malnati, M., Lusso, P., Siccardi, A. G., Lazzarin, A. & Beretta, A. (1997). Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4+ T cells from exposed uninfected individuals expressing the wildtype CCR-5 allele. Journal of Experimental Medicine 186, 455-460.
17. Gotch, F. M., Koup, R. A. & Saffrit, J. T. (1997). New observations on cellular immune responses to HIV and T-cell epitopes. AIDS 11, S99-S107.
18. Haigwood, N. L. & Zolla-Pazner, S. (1998). Humoral immunity to HIV, SIV, and SHIV. AIDS 12 (Suppl. A), S121-S132.
19. Heeney, J. L., Teeuwsen, V. J. P., Van Gils, M., Bogers, W. M. J. M., De Giuli Morghen, C., Radaelli, A., Barnett, S., Morein, B., Åkerblom, L., Wang, Y., Lehner, T. & Davis, D. ( 1998). β-Chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques. Proceedings of the National Academy of Sciences, USA 95, 10803-10808.
20. Hill, C. M., Deng, H., Unutmaz, D., KewalRamani, V. N., Bastiani, L., Gorny, M. K., Zolla-Pazner, S. & Littman, D. R. (1997). Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interaction with this chemokine receptor. Journal of Virology 71, 6296-6304.
21. Kannagi, M., Chalifoux, L. V., Lord, C. I. & Letvin, N. L. (1988). Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes. Journal of Immunology 140, 2237-2242.
22. Kinter, A. L., Ostrowski, M., Goletti, D., Oliva, A., Weissman, D., Gantt, K., Hardy, E., Jackson, R., Ehler, L. & Fauci, A. S. (1996). HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous β-chemokines and the viral inductive effects of other endogenous cytokines. Proceedings of the National Academy of Sciences, USA 93, 14076-14081.
23. Landay, A. L., Mackewicz, C. E. & Levy, J. A. (1993). An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clinical Immunology & Immunopatholgy 69, 106-116.
24. Lehner, T., Wang, Y., Cranage, M., Bergmeier, L. A., Mitchell, E., Tao, L., Hall, G., Dennis, M., Cook, N., Brookers, R., Klavinskis, L., Jones, I., Doyle, C. & Ward, R. (1996). Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nature Medicine 2, 767-775.
25. Levy, J. A., Mackewicz, C. E. & Barker, E. (1996). Controlling HIV pathogenesis: the role of noncytotoxic anti-HIV response of CD8+ T cells. Immunology Today 17, 217-224.
26. Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A. & Landau, N. R. (1996). Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-377.
27. Mackewicz, C. E., Yang, L. C., Lifson, J. D. & Levy, J. A. (1994). Noncytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection. Lancet 344, 1671-1673.
28. Mackewicz, C. E., Blackborn, D. J. & Levy, J. A. (1995). CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proceedings of the National Academy of Sciences, USA 92, 2308-2312.
29. Mackewicz, C. E., Barker, E., Greco, G., Reyes-Teran, G. & Levy, J. A. (1997). Do β-chemokines have clinical relevance in HIV infection? Journal of Clinical Investigation 100, 921-930.
30. Meyer, L., Magierowska, M., Hubert, J. B., Rouzioux, C., Deveau, C., Sanson, F., Debre, P., Delfraissy, J. F., Theodorou, I. and the SEROCO study group. (1997). Early protective effect of CCR-5 Δ32 heterozygosity on HIV-1 disease progression: relationship with viral load. AIDS 11, F73-F78.
31. Nilsson, C., Thorstensson, R., Gilljam, G., Sjölander, S., Hild, K., Broliden, K., Åkerblom, L., Morein, B., Biberfeld, G. & Putkonen, P. (1995). Protection against monkey-cell grown cell-free HIV-2 challenge in macaques immunized with native HIV-2 envelope glycoprotein gp125. Vaccine Research 4, 165-175.
32. Nilsson, C., Mäkitalo, B., Thorstensson, R., Norley, S., Binniger-Schinzel, D., Cranage, M., Rud, E., Biberfeld, G. & Putkonen, P. (1998). Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm. AIDS 12, 2261-2270.
33. Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, J.-L., Arenzana-Seisdedos, F., Schwartz, O., Heard, J.-M., Clark-Lewis, I., Legler, D. F., Loetscher, M., Baggiolini, M. & Moser, B. (1996). The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382, 833-835.
34. Pal, R., Garzino-Demo, A., Markham, P. D., Burns, J., Brown, M., Gallo, R. C. & DeVico, A. L. (1997). Inhibition of HIV-1 infection by the β-chemokine MDC. Science 278, 695-698.
35. SF33 replication mediated by CD8+ T-cell clones. AIDS 10, 1317-1321.
36. Putkonen, P., Nilsson, C., Walther, L., Ghavamzadeh, L., Hild, K., Broliden, K., Biberfeld, G. & Thorstensson, R. (1994). Efficacy of inactivated whole vaccines with various adjuvants in cynomolgus monkeys. Journal of Medical Primatology 3, 89-94.
37. Putkonen, P., Mäkitalo, B., Böttiger, D., Biberfeld, G. & Thorstensson, R. (1997). Protection of human immunodeficiency virus 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission. Journal of Virology 71, 4981-4984.
38. Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Kalams, S. A. & Walker, B. D. (1997). Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278, 1447-1450.
39. Rubbert, A., Weissman, D., Combadiere, C., Pettrone, K. A., Daucher, J. A., Murphy, P. A. & Fauci, A. S. (1997). Multifactorial nature of noncytolytic CD8+ T cell-mediated suppression of HIV replication: β-chemokine-dependent and -independent effects. AIDS Research and Human Retroviruses 13, 63-69.
40. Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R. J., Collman, R. G., Doms, R. W., Vassart, G. & Parmentier, M. (1996). Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722-725.
41. Shearer, G. M. & Clerici, M. (1996). Protective immunity against HIV infection: has nature done the experiment for us? Immunology Today 17, 21-24.
42. Thorstensson, R., Walther, L., Putkonen, P., Albert, J. & Biberfeld, G. (1991). A capture enzyme immunoassay for detection of HIV-2/SIV antigen. Journal of Acquired Immune Deficiency Syndromes 4, 374-379.
43. Walker, C. M. & Levy, J. A. (1989). A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. Immunology 66, 628-630.
44. Walker, C. M., Moody, D. J., Stites, D. P. & Levy, J. A. (1989). CD8+ T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals. Cellular Immunology 119, 470-475.
45. Walker, C. M., Thomson-Honnebier, G. A., Hsueh, F. C., Erickson, A. L., Pan, L.-Z. & Levy, J. A. (1991). CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cellular Immunology 137, 420-428.
46. Zaitseva, M., Blauvelt, A., Lee, S., Lapham, C. K., Klaus-Kovtun, V., Mostowski, H., Manischewits, J. & Golding, H. (1997). Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for primary HIV infection. Nature Medicine 3, 1369-1375.
47. Zou, W., Lackner, A. A., Simson, M., Durand-Gasselin, I., Galanaud, P., Desrosiers, R. C. & Emilie, D. (1997). Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. Journal of Virology 71, 1227-1236.